HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER		Author Keyword(s) Vol Page [Advanced]

This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this link to a friend Similar articles in this journal Similar articles in PubMed Add article to my folders Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Wozniak, M A Articles by Itzhaki, R F Search for Related Content PubMed PubMed Citation Articles by Wozniak, M A Articles by Itzhaki, R F

Apolipoprotein E polymorphisms and risk of malaria

¹ Department of Optometry & Neuroscience, UMIST, Manchester, UK
² Department of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, UK

Correspondence to:
Dr M A Wozniak
Molecular Neurobiology Laboratory, Department of Optometry and Neuroscience, UMIST, Manchester M60 1QD, UK; matthew.a.wozniak@umist.ac.uk]

Keywords: Apolipoprotein E; malaria

The first 150 words of the full text of this article appear below.

Host genetic factors probably determine both susceptibility to infection and severity of damage by pathogens. A large number of polymorphisms have now been implicated in the onset, progression, and outcome of malaria infection, seeming to influence the ability of the host immune response to control the infection. These include:

• those associated with haemoglobinopathies¹
  
• those within the major histocompatibility complex (HMC), including HLA class I and class II and the tumour necrosis factor promoter
  
• those within genes not associated with HMC, such as ICAM-1, CD36, and possibly the gene for nitric oxide synthase²
  
• probably the gene for apolipoprotein E (APOE), as our recent data suggest, and upon which we comment below.³
  

APOE has three main alleles, types 2, 3, and 4, resulting in six possible genotypes; it codes for the protein apoE, which is involved in transport of lipids in the blood and the central nervous system.

Finding . . . [Full text of this article]

This article has been cited by other articles:

				T. D. Burt, B. K. Agan, V. C. Marconi, W. He, H. Kulkarni, J. E. Mold, M. Cavrois, Y. Huang, R. W. Mahley, M. J. Dolan, et al. Apolipoprotein (apo) E4 enhances HIV-1 cell entry in vitro, and the APOE {varepsilon}4/{varepsilon}4 genotype accelerates HIV disease progression PNAS, June 24, 2008; 105(25): 8718 - 8723. [Abstract] [Full Text] [PDF]